MAPT and Alzheimer disease: Measurement of plasma tau phosphorylated at various epitopes, including P-tau181, P-tau217, and P-tau231, has high accuracy in differentiating cognitive impairment due to AD from cognitive impairment caused by other conditions, with plasma P-tau217 consistently showing the highest diagnostic performance (95–102).